The Prognostic Effect of Changes in Tumor Stage and Nodal Status After Neoadjuvant Chemotherapy in Each Primary Breast Cancer Subtype

Our results revealed that changes in tumor stage and nodal status after NAC might be prognostic markers in patients with HR+/HER2−/NG-high tumors or HR−/HER2− tumors, even if there are residual tumors in the breast.